Fifth Third Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Fifth Third Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$510K	Sell	969 -210	-18%	-$118K	0.01%	475
2026 Q1	$662K	Buy	1,179 +287	+32%	+$184K	0.02%	345
2025 Q4	$603K	Sell	892 -23	-3%	-$15.7K	0.02%	346
2025 Q3	$585K	Buy	915 +14	+2%	+$8.5K	0.02%	335
2025 Q2	$483K	Sell	901 -94	-9%	-$45K	0.02%	375
2025 Q1	$418K	Buy	995 +11	+1%	+$4.78K	0.02%	378
2024 Q4	$407K	Buy	984 +149	+18%	+$65.4K	0.02%	390
2024 Q3	$422K	Buy	835 +83	+11%	+$40.3K	0.03%	354
2024 Q2	$366K	Buy	+752	New	+$378K	0.03%	359

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Fifth Third Wealth Advisors's IDXX Position: Q2 2026 in Review

Fifth Third Wealth Advisors reduced its Idexx Laboratories (IDXX) stake by 18% in Q2 2026, selling an estimated $118K and leaving 969 shares worth $510K. The position accounts for 0.01% of the portfolio, ranked #475.

Fifth Third Wealth Advisors first reported a position in IDXX in Q2 2024 and has held it in 9 quarters since. The position peaked at $662K in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Fifth Third Wealth Advisors held 969 shares of Idexx Laboratories worth $510K as of Q2 2026.
Fifth Third Wealth Advisors sold 210 Idexx Laboratories shares in Q2 2026, an estimated $118K.
Idexx Laboratories made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #475 holding.
Fifth Third Wealth Advisors first reported a position in Idexx Laboratories in Q2 2024 and has held it in 9 quarters since.
Fifth Third Wealth Advisors's Idexx Laboratories position peaked at $662K in Q1 2026.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.